对失眠和持续疼痛患者的"SleepWell"干预:一种随机等待列表对照试验的研究方案
Jan H Rosenvinge1, Svein Bergvik1, Karin Abeler2
1Faculty of Health Sciences, Department of Psychology, UiT - The Arctic University of Norway, 9037, Tromsø, Norway.
Trials
|August 27, 2025
概括
对于慢性疼痛和失眠的患者来说,认知行为疗法 (CBT-i) 是有前途的. 这项研究评估了CBT-i
科学领域:
- 治疗疼痛
- 睡眠医学
- 心理干预
背景情况:
- 持续的疼痛和失眠往往同时存在,造成症状恶化的循环并影响日常生活.
- 这种并发症与抑郁和疲劳有关,强调需要有效的治疗方法.
- 对于睡眠问题,认知行为疗法 (CBT-i) 是有效的,但其在伴随性疼痛患者中的使用尚未得到充分研究.
研究的目的:
- 评估CBT-i在改善伴随性持续性疼痛患者的核心失眠症状方面的有效性.
- 评估CBT-i对次要结果的影响,包括疼痛强度,抑郁,疲劳,疼痛接受和生活质量.
- 探索患者对CBT-i可行性和可接受性的经验,并确定治疗效果的潜在媒介.
主要方法:
- 一项随机对照试验,涉及106名诊断为慢性疼痛和失眠的医院患者 (DSM-5).
- 在10周的时间内,参与者将被随机分组为基于组的CBT-i或通常的治疗 (TAU).
- 将使用治疗意图原则分析数据,并在4个月和12个月后进行后续评估. 根据主题分析患者的经验.
主要成果:
- *由于研究正在进行/最近注册,结果尚未公布) *
- *预期的结果将集中在改善睡眠开始,减少醒来,提高睡眠效率和减少白天障碍. 没有.
- *二次结果分析将检查疼痛,抑郁,疲劳,疼痛接受和生活质量的变化. 没有.
结论:
- 这项研究旨在填补适应性认知治疗对伴随性失眠和非恶性疼痛患者的有效性方面的知识差距.
- 积极的结果可以支持将心理睡眠干预措施纳入睡眠障碍患者的日常护理.
- 这些发现可以为管理这种复杂的患者群体提供临床建议.
相关概念视频
01:27Insomnia
124
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
124
01:19Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
02:07Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238
01:14CNS Depressants: Barbiturates and Benzodiazepines
466
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
466
01:23Sedatives and Hypnotics: Overview
636
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
636